Suavinex

Suavinex Zero Zero Anti-Colic Bottle - Medium Flow - 270ml - Medium

12.69
Delivery icon

Free delivery from 35 euro

  • Ordered before 23:59, delivered next working day
  • Free exchange and return within 14 days
Store icon

Pickup at Kesteren

  • Not in stock and display model is not available
12.69
Member icon
Earn 13 Member points info


Suavinex Baby Bottle - Zero Zero - Medium Flow 270ml - Medium

The Suavinex Baby Bottle - Zero Zero - Medium Flow 270ml - Medium offers a perfect balance between functionality and style. The warm earthy tone "Medium" gives this bottle a modern look, while the ergonomic design ensures optimal ease of use. The medium flow nipple is suitable for babies from around 3 months and provides a steady milk flow for slightly stronger sucking behavior.

The integrated anti-colic system significantly reduces air intake during feeding, thereby limiting stomach cramps, reflux, and discomfort. The nipple is shaped after the mother's breast, making this bottle particularly suitable for parents who want to combine breastfeeding and bottle feeding.

With a capacity of 270 ml and clear measurement markings in milliliters and fl. oz, this bottle is ideal for daily feedings. The durable, BPA-free material is safe for your little one and easy to clean. A smart choice for parents who don’t want to compromise on quality, comfort, and style.

Features

  • - Capacity: 270 ml
  • - Medium flow nipple for babies from approx. 3 months
  • - Anti-colic system reduces air intake
  • - Natural-shaped nipple, ideal for combination with breastfeeding
  • - Ergonomic design, comfortable to hold
  • - Color: Medium (warm earthy tone)
  • - Clear measurement markings in ml and fl. oz
  • - Made from BPA-free and durable material
  • - Easy to clean
More from Suavinex

Don't miss any offers?

We'd love to keep you informed of new developments and alert you to exciting discounts through our newsletter. By providing your email address, you're subscribing to our newsletter and will be kept up-to-date on interesting news.

Please log in to proceed